#195 - Wonder drugs
About this episode
Andy and Roger discuss the implications of GLP-1 drugs on obesity, behavior, and societal norms around eating.
🎧 NEW PODCAST EPISODE Episode 195 – Wonder drugs Roger is back in Brisbane, the weather is terrible, and after briefly contemplating the bleakness of bachelor apartment living, Andy and Roger turn their attention to the latest supposed miracle of modern medicine: GLP-1 drugs such as Ozempic, Wegovy and Mounjaro. They explore how these drugs are changing the conversation around obesity, willpower and the constant background hum of “food noise”. If a drug can dramatically reduce hunger and cravings, does that challenge the idea that losing weight is simply a matter of discipline? And if GLP-1s can influence our desire for food—and potentially other rewards—what happens when medicine starts changing not just our bodies, but our behaviour? The discussion broadens to the potential impact on restaurants, alcohol, fast food and a society built around eating and drinking, as well as the inequality created when effective treatments are available to those who can afford them. Andy and Roger also debate whether using weight-loss drugs is “cheating”, whether governments should subsidise them, and whether scepticism about a medical shortcut carries its own risks. Ultimately, they ask whether…
People in this episode
Hosts: Andy, Roger
Topics covered
- modern medicine
- obesity
- weight loss
- pharmaceuticals
- food behavior
- health inequality
Keywords
- Ozempic
- GLP-1
- WeightLoss
- Wegovy
- Mounjaro
- Obesity
- FoodNoise
- WeightLossDrugs
- Health
- ModernMedicine
Mentioned in this episode
Products: GLP-1 drugs, Ozempic, Wegovy, Mounjaro
Places: Brisbane
More episodes of The Middle
- #194 - Trump card
- #193 - Monoculture
- #192 - Karl Stefanovic
- #191 - Cloudy reflections
- #190 - One Nation
Explore listener stats, chart rankings, contacts and more on the The Middle podcast page.